SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000122
Filing Date
2019-12-16
Accepted
2019-12-16 08:34:15
Documents
3
Period of Report
2019-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201912168xkdoc.htm 8-K 28009
2 PRESS RELEASE pdli-201912168xkex991.htm EX-99.1 13220
3 pdllogo2a06.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000122.txt   211845
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 191286037
SIC: 2836 Biological Products, (No Diagnostic Substances)